Plato Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39K Hold
5
– – ﹤0.01% 487
2026
Q1
$1.33K Hold
5
– – ﹤0.01% 504
2025
Q4
$1.26K Hold
5
– – ﹤0.01% 501
2025
Q3
$1.42K Hold
5
– – ﹤0.01% 505
2025
Q2
$1.31K Hold
5
– – ﹤0.01% 507
2025
Q1
$1.18K Hold
5
– – ﹤0.01% 518
2024
Q4
$1.15K Hold
5
– – ﹤0.01% 574
2024
Q3
$1.12K Hold
5
– – ﹤0.01% 536
2024
Q2
$1.02K Hold
5
– – ﹤0.01% 491
2024
Q1
$1.09K Hold
5
– – ﹤0.01% 476
2023
Q4
$1.14K Buy
+5
New +$1.05K ﹤0.01% 436

Other funds holding LH

Plato Investment Management's LH Position: Q2 2026 in Review

Plato Investment Management held its Labcorp (LH) position steady in Q2 2026 at 5 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

Plato Investment Management first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.42K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Plato Investment Management held 5 shares of Labcorp worth $1.39K as of Q2 2026.
  • Plato Investment Management left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of Plato Investment Management's portfolio in Q2 2026, its #487 holding.
  • Plato Investment Management first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Plato Investment Management's Labcorp position peaked at $1.42K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.